Phio Pharmaceuticals (PHIO) FCF Margin (2012 - 2019)

Phio Pharmaceuticals (PHIO) has reported FCF Margin for 8 consecutive years, with 10361.9% the latest figure, recorded in Q1 2019.

• For the quarter ending Q1 2019, FCF Margin fell 207060.0% year-over-year to 10361.9%; the trailing twelve-month figure through Dec 2019 stood at 41509.52% (down 3605663.0% YoY), and the FY2019 full-year result was 41509.52%, down 3605663.0% from the prior year.
• FCF Margin eased to 10361.9% in Q1 2019 per PHIO's latest filing, from 3521.05% in the prior quarter.
• Across five years, FCF Margin topped out at 3206.9% in Q2 2018 and bottomed at 29250.0% in Q1 2016.
• Historically, FCF Margin has averaged 11974.34% across 5 years, with a median of 9326.6% in 2018.
• The sharpest annual moves came in 2015 and 2016: FCF Margin soared 238337 bps in 2015, then plunged 2342647 bps in 2016.
• Over 5 years, FCF Margin stood at 5823.53% in 2015, then plunged by 255 bps to 20666.67% in 2016, then grew by 29 bps to 14673.33% in 2017, then jumped by 76 bps to 3521.05% in 2018, then plunged by 194 bps to 10361.9% in 2019.
• According to Business Quant data, FCF Margin over the past three periods registered 10361.9%, 3521.05%, and 3206.9% for Q1 2019, Q3 2018, and Q2 2018 respectively.